16 unknown, 14 recruiting, 4 completed, 3 terminated. 41 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 41 | Unknown 16, Recruiting 14, Completed 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1 |
Follow Solid Tumor: new trials by email Literature Review of Solid Tumor trials Research Report on Solid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors ABO2109 Injection, Toripalimab - Solid Tumor | Early Phase 1 | Recruiting | Ruijin Hospital | 60 | 2026-06-09 | 2026-08-03 |
| Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors Enhanced ALPP CAR-T treatment - Solid Tumor | Early Phase 1 | Recruiting | TCRCure Biopharma Ltd. | 24 | 2026-02-28 | 2026-03-23 |
| TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors TCR-T cells, Fludarabine, Cyclophosphamide - KRAS G12V, KRAS G12D | Early Phase 1 | Not yet recruiting | Sun Yat-sen University | 25 | 2026-02-01 | 2026-01-15 |
| This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors IBI3026 - Solid Tumor | Early Phase 1 | Recruiting | Innovent Biologics Technology Limited (Shanghai R&D Center) | 300 | 2026-01-29 | 2026-02-04 |
| Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors Anti ALPP CAR-T cells treatment - Solid Tumor | Early Phase 1 | Terminated | TCRCure Biopharma Ltd. | 5 | 2025-05-20 | 2026-01-22 |
| PET-imaging of Two Vartumabs in Patients With Solid Tumors 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma | Early Phase 1 | Recruiting | Var2 Pharmaceuticals | 32 | 2024-12-10 | 2025-12-29 |
| An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours LM303 - Solid Tumor | Early Phase 1 | Recruiting | Suzhou BlueHorse Therapeutics Co., Ltd. | 10 | 2024-10-17 | 2024-11-19 |
| HS-IT201 Injection in the Treatment of Advanced Solid Tumors HS-IT201 Injection - Solid Tumor | Early Phase 1 | Not yet recruiting | Hangzhou Huasai Biomedicine Co., Ltd. | 9 | 2024-10-01 | 2024-09-25 |
| Genetically Modified T Cells Treating Malignant Tumors CAR-T cell reinfusion - Solid Tumor | Early Phase 1 | Recruiting | Yi Zhang | 100 | 2024-08-18 | 2024-09-25 |
| An Exploratory Study by Fast CAR T Cells Fast CAR T cells - Solid Tumor | Early Phase 1 | Recruiting | Shanghai Cell Therapy Group Co.,Ltd | 20 | 2024-03-07 | 2024-03-25 |
| Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors Indocyanine Green - Solid Tumor | Early Phase 1 | Recruiting | St. Jude Children's Research Hospital | 35 | 2023-10-24 | 2026-10-30 |
| A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors LM103 - Solid Tumor | Early Phase 1 | Unknown | Suzhou BlueHorse Therapeutics Co., Ltd. | 5 | 2023-08-01 | 2023-08-02 |
| A Clinical Study on TILs for the Treatment of Advanced Solid Tumors LM103 - Solid Tumor | Early Phase 1 | Unknown | Suzhou BlueHorse Therapeutics Co., Ltd. | 20 | 2023-08-01 | 2023-08-02 |
| An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells Fast CAR T cells - Solid Tumor | Early Phase 1 | Recruiting | Shanghai Cell Therapy Group Co.,Ltd | 12 | 2023-06-01 | 2024-02-08 |
| Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors BEN101 - Solid Tumor | Early Phase 1 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 16 | 2023-05-23 | 2024-09-19 |
| A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors LM103 - Solid Tumor | Early Phase 1 | Unknown | Suzhou BlueHorse Therapeutics Co., Ltd. | 5 | 2023-05-19 | 2023-07-12 |
| Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors GT316 - Solid Tumor, Adult | Early Phase 1 | Terminated | Grit Biotechnology | 2 | 2023-02-26 | 2026-04-29 |
| Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors GT201 - Solid Tumor | Early Phase 1 | Unknown | RenJi Hospital | 24 | 2023-02-01 | 2023-02-13 |
| Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies engineered red blood cell - Cancer, Solid Tumor | Early Phase 1 | Unknown | Westlake Therapeutics | 30 | 2023-01-16 | 2024-07-24 |
| Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors αPD1/CTLA4-MSLN-CAR T cells - Solid Tumor | Early Phase 1 | Recruiting | Shanghai Cell Therapy Group Co.,Ltd | 16 | 2023-01-01 | 2024-02-08 |
Showing 20 of 41. Sign in to see all of them.
Neoplasms (3) · Breast Neoplasms (2) · Pancreatic Neoplasms (2) · Sarcoma (2) · Squamous Cell Carcinoma of Head and Neck (2) · Stomach Neoplasms (2) · Chondrosarcoma (1) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Head and Neck Neoplasms (1) · Hematologic Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Melanoma (1)
Neoplasms by Site (5) · Neoplasms (4) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Breast Diseases (2) · Carcinoma (2) · Carcinoma, Squamous Cell (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2)
Cyclophosphamide (3) · fludarabine (3) · alpha-Synuclein (2) · Alemtuzumab (1) · Aspirin (1) · Bevacizumab (1) · Carboxylesterase (1) · Cyclosporine (1) · Cyclosporins (1) · Etoposide (1) · Fibroblast Growth Factor 7 (1) · Fluorodeoxyglucose F18 (1) · Indocyanine Green (1) · Interleukin-2 (1) · KD025 (1)
Suzhou BlueHorse Therapeutics Co., Ltd. (4) · Shanghai Cell Therapy Group Co.,Ltd (3) · Allife Medical Science and Technology Co., Ltd. (2) · SmartNuclide Biopharma (2) · TCRCure Biopharma Ltd. (2) · jianming xu (2) · Affiliated Hospital of Jiangnan University (1) · Case Comprehensive Cancer Center (1) · Fujian Cancer Hospital (1) · Grit Biotechnology (1) · Hangzhou Huasai Biomedicine Co., Ltd. (1) · Innovent Biologics Technology Limited (Shanghai R&D Center) (1) · Miller Children's & Women's Hospital Long Beach (1) · Montefiore Medical Center (1) · Peking University (1)
China (23) · United States (7) · Netherlands (1) · South Korea (1)
Jinxing Lou (3) · Liyan Miao, Ph.D (2) · Songbing Qin (2) · Tangfeng Lv, MD (2) · Alok A Khorana, MD (1) · Andrew Davidoff, MD (1) · Baiyong Shen (1) · Chunjing Yu (1) · Gooitzen van Dam, MD, PhD (1) · Hongxia Wang, Doctor (1) · Howard Lee, MD, PhD (1) · Kris M Mahadeo, MD,MPH (1) · Laura Klesse, MD, PhD (1) · Leslie Fecher (1) · Lin Shen, Prof. Dr. (1)